Ambient particles related to pulmonary function tests (PFTs) can be reduced in laboratories with moderate aggressive ventilation exchanges, suggesting PFTs can be safely conducted during the COVID-19 pandemic.
This is the first time the Agency has authorized a COVID-19 diagnostic test that provides rapid results at home.
Study authors assessed the effectiveness of high-dose influenza vaccines in patients with HIV during the 2017-2018 influenza season.
Investigators compared the prevalence of HIV among patients hospitalized with COVID-19 compared to the general population and sought to determine whether patients with HIV had higher susceptibility to COVID-19.
The study, which was fully remote and contactless, aimed to evaluate whether early treatment with fluvoxamine reduced the likelihood of clinical deterioration and disease severity in patients with mild COVID-19 illness.
A higher neutrophil count predicted worse disease course and higher long-term mortality in patients with systemic sclerosis-related interstitial lung disease.
In a new study, researchers reported on the frequency of VTE among more than 6000 patients who tested positive for infection with SARS-CoV-2.
NVX-CoV2373 is engineered from the genetic sequence of severe acute respiratory syndrome coronavirus 2 using the recombinant nanoparticle technology to generate antigen derived from the coronavirus spike (S) protein.